Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT), a Phase I Prospective Randomized Controlled Trial

NCT05652218 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT05652218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05652218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT), a Phase I Prospective Randomized Controlled Trial
Lead sponsor
Inova Health Care Services
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 26, 2023
Completion date
September 30, 2026
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure (hf), left bundle-branch block, left ventricular ejection fraction